Why Fewer Clinical Trials in Africa is Bad for Innovation

"The African continent offers many of the best conditions for conducting clinical trials. It has a diverse population of potential patients, and many have not been previously exposed to any kind of pharmaceutical drugs ... So it makes sense to run clinical trials for drugs that would treat diseases endemic to the developing world in the areas most affected by them," writes Swapan Kumar Patra for The Conversation.

Photo: Pexels

(file photo).

See What Everyone is Watching